Publication & Citation Trends
Most Cited Works
Publications
41 total
NatHER: protocol for systematic evaluation of trends in survival among patients with HER2-positive advanced breast cancer PDF
Cited by 3
OpenAlex
High rates of early treatment discontinuation in hepatitis C-infected US veterans PDF
Cited by 9
OpenAlex
Absolute and relative contraindications to pegylated‐interferon or ribavirin in the <scp>US</scp> general patient population with chronic hepatitis C: results from a <scp>US</scp> database of over 45 000 <scp>HCV</scp>‐infected, evaluated patients PDF
Cited by 45
OpenAlex
Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver disease
Cited by 25
OpenAlex
Impact of age on viral kinetics of peginterferon alfa‐2a/ribavirin in chronic hepatitis C: final analysis from the <scp>PROPHESYS</scp> cohort PDF
Cited by 5
OpenAlex
Improving Prescribing Safety in Patients with Renal Insufficiency in the Ambulatory Setting: The Drug Renal Alert Pharmacy (DRAP) Program
Cited by 63
OpenAlex
Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting
Cited by 43
OpenAlex
Research Topics
Breast Cancer Treatment Studies
(13)
Hepatitis C virus research
(12)
HER2/EGFR in Cancer Research
(12)
Advanced Breast Cancer Therapies
(12)
Liver Disease Diagnosis and Treatment
(6)
Frequent Co-Authors
Affiliations
Roche (Switzerland)
Roche (United States)
Kaiser Permanente
Cerner (United States)
University of Colorado Health